Are all estrogens the same?
- PMID: 15063479
- DOI: 10.1016/j.maturitas.2003.11.009
Are all estrogens the same?
Abstract
This paper focuses on the question whether different estrogens (E) have different qualitative pharmacodynamic effects when used by women for contraception, Hormone Replacement Therapy (HRT) or prevention of osteoporosis. In this context estrogens have been defined as the estrogen agonists estradiol (E2), estrone (E1), estriol (E3), conjugated equine estrogens (CEE), diethylstilbestrol (DES) and ethinylestradiol (EE). Selective Estrogen Receptor Modulator's (SERM's) have been excluded from this analysis primarily because of lack of comparative (clinical) data with estrogen agonists. A major problem when addressing the issue of comparability of estrogen agonists is the lack of data from head-to-head estrogen-only comparative studies. Comparative studies have been performed almost exclusively with estrogen agonists combined with a series of different progestogens (P), that have been added to protect the uterus from endometrial hyperplasia. Since progestogens are known to exhibit different intrinsic pharmacodynamic properties and interactions with estrogens, it is impossible to judge which role the estrogen plays when qualitative differences between different combined E/P preparations are observed. In summary, no convincing evidence has been found that the estrogens mentioned differ qualitatively. Obviously quantitative differences are present due to differences in e.g. receptor affinity, metabolism (half life) and route of administration (transdermal/vaginal). Since DES has been discarded for human use due to teratogenicity, EE used in all combined E/P oral contraceptives is the most potent estrogen agonist available at present. In HRT, E2 and CEE are equally effective for the treatment of hot flushes and urogenital atrophy and superior to any other treatment option. For long term treatment to prevent osteoporosis and even for short term HRT, estrogen agonists are heavily debated recently because of a small increased risk of breast cancer, that has been known for a long time already. Well informed and individualised choice of treatment seems the appropriate solution.
Republished in
-
Reprint of Are all estrogens the same?Maturitas. 2008 Sep-Oct;61(1-2):195-201. doi: 10.1016/j.maturitas.2008.11.015. Maturitas. 2008. PMID: 19434891
Similar articles
-
Reprint of Are all estrogens the same?Maturitas. 2008 Sep-Oct;61(1-2):195-201. doi: 10.1016/j.maturitas.2008.11.015. Maturitas. 2008. PMID: 19434891
-
Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.Metabolism. 2009 Jan;58(1):1-7. doi: 10.1016/j.metabol.2008.07.016. Metabolism. 2009. PMID: 19059524 Clinical Trial.
-
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.
-
Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.Maturitas. 2006 Aug 20;55(1):69-75. doi: 10.1016/j.maturitas.2006.01.005. Epub 2006 Feb 24. Maturitas. 2006. PMID: 16500052 Clinical Trial.
-
Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.J Womens Health (Larchmt). 2003 Oct;12(8):723-47. doi: 10.1089/154099903322447701. J Womens Health (Larchmt). 2003. PMID: 14588124 Review.
Cited by
-
Estradiol enhanced neuronal plasticity and ameliorated astrogliosis in human iPSC-derived neural models.Regen Ther. 2024 Jan 12;25:250-263. doi: 10.1016/j.reth.2023.12.018. eCollection 2024 Mar. Regen Ther. 2024. PMID: 38293585 Free PMC article.
-
Hormone-based models for comparing menstrual cycle and hormonal contraceptive effects on human resting-state functional connectivity.Front Neuroendocrinol. 2022 Oct;67:101036. doi: 10.1016/j.yfrne.2022.101036. Epub 2022 Sep 17. Front Neuroendocrinol. 2022. PMID: 36126748 Free PMC article.
-
Estradiol (E2) Improves Glucose-Stimulated Insulin Secretion and Stabilizes GDM Progression in a Prediabetic Mouse Model.Int J Mol Sci. 2022 Jun 15;23(12):6693. doi: 10.3390/ijms23126693. Int J Mol Sci. 2022. PMID: 35743136 Free PMC article.
-
Challenging Aspects of Research on the Influence of the Menstrual Cycle and Oral Contraceptives on Physical Performance.Sports Med. 2022 Jul;52(7):1453-1456. doi: 10.1007/s40279-021-01616-5. Epub 2022 Jan 22. Sports Med. 2022. PMID: 35064914 No abstract available.
-
Occurrence of Pharmaceuticals and Endocrine Disrupting Compounds in Brazilian Water and the Risks They May Represent to Human Health.Int J Environ Res Public Health. 2021 Nov 9;18(22):11765. doi: 10.3390/ijerph182211765. Int J Environ Res Public Health. 2021. PMID: 34831521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources